EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

SPNS1 variants cause multiorgan disease and implicate lysophospholipid transport as critical for mTOR-regulated lipid homeostasis

Menglan He, Mei Ding, Michaela Chocholouskova, Cheen Fei Chin, Martin Engvall, Helena Malmgren, Matias Wagner, Marlen C Lauffer, Jacob Heisinger, May Christine V Malicdan, Valerie Allamand, Madeleine Durbeej und 5 weitere

Journal of Clinical Investigation · 2025

DOI: 10.1172/jci193099 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Investigation, 2025. Verfasst von Menglan He und 16 weiteren Autor:innen. Beteiligte Einrichtung: Signature Research Program in Cardiovascular and Metabolic Disorders, Duke-NUS Medical School, Singapore. Hauptthemen laut MEDLINE: TOR Serine-Threonine Kinases, Lysophospholipids, Homeostasis, Lipid Metabolism. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Health Singapore, Ministry of Education Singapore, Goh Cardiovascular Research Award.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

SPNS1 is a lysosomal transporter that mediates the salvage of lysoglycerophospholipids, the degradative products of lysosomal phospholipid catabolism. However, an understanding of the role of lysolipid transport and salvage in regulating cellular lipid homeostasis and in disease is lacking. Here, we identified members of 2 families with biallelic SPNS1 loss-of-function variants, who presented primarily with progressive liver and striated muscle injury. Patients’ fibroblasts accumulated lysophospholipids including lysoplasmalogens and cholesterol in lysosomes with reduced cellular plasmalogens. Notably, SPNS1 deficiency resulted in reduced biogenesis of cytosolic lipid droplets containing triglycerides and cholesteryl esters. Mechanistically, we found that lysophospholipids transported by SPNS1 into the cytosol quantitatively contributed to triglyceride synthesis, whereas lysosomal buildup of lyso-ether-phospholipid inhibited lysosomal cholesterol egress, effects that were enhanced with inhibition of mTOR. These findings support a gene-disease association and reveal connectivity between lysosomal transport of lysophospholipids and storage of reserve cellular energy as triglycerides and the regulation of cholesterol homeostasis, processes that become important under nutrient limitation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TOR Serine-Threonine KinasesLysophospholipidsHomeostasisLipid MetabolismLoss of Function MutationHumansLysosomesMaleFemaleBiological TransportFibroblastsAnimalsMice

Stichwörter der Autor:innen

Cell biologyCholesterolLipidomicsLysosomesMetabolism

Substanzen

TOR Serine-Threonine KinasesLysophospholipidsMTOR protein, human

Autor:innen und Institutionen

  • Signature Research Program in Cardiovascular and Metabolic Disorders, Duke-NUS Medical School, Singapore.
  • Singapore Lipidomics Incubator (SLING), Life Sciences Institute, and.
  • Precision Medicine Translational Research Programme and Department of Biochemistry, YLL School of Medicine, National University of Singapore, Singapore.
  • Centre for Inherited Metabolic Diseases, Karolinska University Hospital, Stockholm, Sweden.
  • Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
  • Department of Clinical Genetics and Genomics, Karolinska University Hospital, Solna, Stockholm, Sweden.

Förderung

  • Ministry of Health Singapore
  • Ministry of Education Singapore
  • Goh Cardiovascular Research Award
  • SingHealth Duke-NUS Genomic Medicine Centre Seed Grant
  • Swedish Childhood Cancer Fund
  • Swedish Research Council
  • German Research Foundation

Zitieren

APA

He, M., Ding, M., Chocholouskova, M., Chin, C. F., Engvall, M., Malmgren, H., Wagner, M., Lauffer, M. C., Heisinger, J., Malicdan, M. C. V., Allamand, V., Durbeej, M., Delgado Vega, A., Sejersen, T., Nordgren, A., Torta, F., & Silver, D. L. (2025). SPNS1 variants cause multiorgan disease and implicate lysophospholipid transport as critical for mTOR-regulated lipid homeostasis. Journal of Clinical Investigation. https://doi.org/10.1172/jci193099

Vancouver

He M, Ding M, Chocholouskova M, Chin CF, Engvall M, Malmgren H, et al. SPNS1 variants cause multiorgan disease and implicate lysophospholipid transport as critical for mTOR-regulated lipid homeostasis. Journal of Clinical Investigation. 2025. doi:10.1172/jci193099

BibTeX
@article{He2025,
  author = {He, Menglan and Ding, Mei and Chocholouskova, Michaela and Chin, Cheen Fei and Engvall, Martin and Malmgren, Helena and Wagner, Matias and Lauffer, Marlen C and Heisinger, Jacob and Malicdan, May Christine V and Allamand, Valerie and Durbeej, Madeleine and Delgado Vega, Angelica and Sejersen, Thomas and Nordgren, Ann and Torta, Federico and Silver, David L},
  title = {SPNS1 variants cause multiorgan disease and implicate lysophospholipid transport as critical for mTOR-regulated lipid homeostasis},
  journal = {Journal of Clinical Investigation},
  year = {2025},
  doi = {10.1172/jci193099}
}
Kostenlos starten →